Can clinical pharmacy services have a positive impact on drug-related problems and health outcomes in community-based older adults?

American Journal Geriatric Pharmacotherapy

Volumn 2, Issue 1, 2004, Pages 3-13

  Hanlon, Joseph T ^a,b,c   Lindblad, Catherine I ^c,d   Gray, Shelly L ^e  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Drug therapy; Elderly; Health care quality; Pharmacist; Randomized controlled trial

Indexed keywords

BENZODIAZEPINE; CARDIOVASCULAR AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYPNOTIC AGENT; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PSYCHOTROPIC AGENT;

AGED; COCHRANE LIBRARY; COMMUNITY CARE; COST EFFECTIVENESS ANALYSIS; DRUG INDICATION; DRUG INDUCED DISEASE; DRUG USE; DRUG WITHDRAWAL; ELDERLY CARE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE FACILITY; HEALTH CARE UTILIZATION; HEALTH STATUS; HEART FAILURE; HOME CARE; HOSPITAL DISCHARGE; HUMAN; INTERPERSONAL COMMUNICATION; INTOXICATION; LONG TERM CARE; MEDICAL LITERATURE; MEDICATION ERROR; MEDLINE; MORBIDITY; MORTALITY; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT EDUCATION; PHARMACEUTICAL CARE; PHARMACIST; PHARMACY; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; QUALITY OF LIFE; REVIEW; TIME; TREATMENT FAILURE; TREATMENT PLANNING;

EID: 2342436916     PISSN: 15435946     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1543-5946(04)90002-5     Document Type: Review

References (44)

1. Strand LM, Morley PC, Cipolle RJ, et al. Drug-related problems: Their structure and function. Drug Intell Clin Pharm. 1990;24:1093-1097.
2. Hanlon JT, Lindblad CI, Maher R, Schmader KE. Geriatric pharmacotherapy. In: Tallis R, Fillit HM, eds. Brocklehurst's Textbook of Geriatric Medicine. 6th ed. London: Churchill Livingstone; 2003:1289-1296.
3. Kohn L, Corrigan J, Donaldson M, eds, for the Committee on Quality of Health Care in America, Institute of Medicine. To Err Is Human: Building a Safer Health System. Washington, DC: National Academy Press; 1999.
4. Hanlon JT, Schmader K, Gray S. Adverse drug reactions. In: Delafuente JC, Stewart RB, eds. Therapeutics in the Elderly. 3rd ed. Cincinnati, Ohio: Harvey Whitney Books; 2000:289-314.
5. Farris KB, Kirking DM. Assessing the quality of pharmaceutical care. II. Application of concepts of quality assessment from medical care. Ann Pharmacother. 1993;27: 215-223.
6. Lohr KN. Outcome measurement: Concepts and questions. Inquiry. 1988;25:37-50.
7. Branch LG. Communitv long-term care services: What works and what doesn't? Gerontologist. 2001;41:305-306.
8. Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: Updating the cost-of-illness model. J Am Pharm Assoc (Wash). 2001;41:192-199.
9. Bootman JL, Harrison DL, Cox E. The health care cost of drug-related morbidity and mortality in nursing facilities. Arch Intern Med. 1997;157:2089-2096.
10. Adamcik BA, Rhodes RS. The pharmacist's role in rational drug therapy of the aged. Drugs Aging. 1993;3:481-486.
11. Dyer CC, Oles KS, Davis SW. The role of the pharmacist in a geriatric nursing home: A literature review. Drug Intell Clin Pharm. 1984;18:428-433.
12. Owens NJ, Silliman RA, Fretwell MD. The relationship between comprehensive functional assessment and optimal pharmacotherapy in the older patient. Drug Intell Clin Pharm. 1989;23:847-854.
13. Soumerai SB, Majumdar SR, Lipton HL. Evaluating and improving physician prescribing. In: Strom BL, ed. Pharmacoepidemiology. 3rd ed. Toronto: John Wiley & Sons; 2000:483-503.
14. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: Scientific review. JAMA. 2002;288:2868-2879.
15. Kidder SW. Cost benefit of pharmacist-conducted medication reviews. Consult Pharm. 1987;2:394-398.
16. McGhan WF, Einarson TR, Sabers DL, Gardner ME. A meta-analysis of the impact of pharmacist drug regimen reviews in long term care facilities. J Geriatr Drug Ther. 1987;1:23-34.
17. Gurwitz JH, Soumerai SB, Avorn J. Improving medication prescribing and utilization in the nursing home. J Am Geriatr Soc. 1990;38:542-552.
18. Hanlon JT, Schmader KE, Ruby CM, Weinberger M. Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc. 2001;49:200-209.
19. Tett SE, Higgins GM, Armour CL. Impact of pharmacist interventions on medication management by the elderly: Review of the literature. Ann Pharmacother. 1993;27: 80-86.
20. Haynes RB, McDonald H, Garg AX, Montague P. Interventions for helping patients to follow prescriptions for medications (Cochrane Methodology Review). In: The Cochrane Library. Chichester, UK: John Wiley & Sons; Issue 4, 2003.
21. Singhal PK, Raisch DW, Gupchup GV. The impact of pharmaceutical services in community and ambulatory care settings: Evidence and recommendations for future research. Ann Pharmacother. 1999;33:1336-1355.
22. Beney J, Bero LA, Bond C. Expanding the roles of outpatient pharmacists: Effects on health services utilisation, costs, and patient outcomes (Cochrane Methodology Review). In: The Cochrane Library. Chichester, UK: John Wiley & Sons; Issue 4, 2003.
23. Lipton HL, Byrns PJ, Soumerai SB, Chrischilles EA. Pharmacists as agents of change for rational drug therapy. Int J Technol Assess Health Care. 1995;11:484-508.
24. Monane M, Matthias DM, Nagle BA, Kelly MA. Improving prescribing patterns for the elderly through an online drug utilization review intervention: A system linking the physician, pharmacist, and computer. JAMA. 1998;1280:1249-1252.
25. Thompson JF, McGhan WF, Ruffalo RL, et al. Clinical pharmacists prescribing drug therapy in a geriatric setting: Outcome of a trial. J Am Geriatr Soc. 1984;32: 154-159.
26. Kimberlin CL, Berardo DH, Pendergast JF, McKenzie LC. Effects of an education program for community pharmacists on detecting drug-related problems in elderly patients. Med Care. 1993;31:451-468.
27. Lowe CJ, Raynor DK, Purvis J, et al. Effects of a medicine review and education programme for older people in general practice. Br J Clin Pharmacol. 2000;50:172-175.
28. Sidel VW, Beizer JL, Lisi-Fazio D, et al. Controlled study of the impact of educational home visits by pharmacists to high-risk older patients. J Community Health. 1990; 15:163-174.
29. Begley S, Livingstone C, Hodges N, Williamson V. Impact of domiciliary pharmacy visits on medication management in an elderly population. Int J Pharm Pract. 1997;5:111-121.
30. Krska J, Cromarty JA, Arris F, et al. Pharmacist-led medication review in patients over 65: A randomized, controlled trial in primary care. Age Ageing. 2001;30:205-211.
31. Meredith S, Feldman P, Frey D, et al. Improving medication use in newly admitted home healthcare patients: A randomized controlled trial. J Am Geriatr Soc. 2002;50:1484-1491.
32. Goodyer LI, Miskelly F, Milligan P. Does encouraging good compliance improve patients' clinical condition in heart failure? Br J Clin Pract. 1995;49:173-176.
33. Lipton HL, Bero LA, Bird JA, McPhee SJ. The impact of clinical pharmacists' consultations on physicians' geriatric drug prescribing. A randomized controlled trial. Med Care. 1992;30:646-658.
34. Lipton HL, Bird JA. The impact of clinical pharmacists' consultations on geriatric patients' compliance and medical care use: A randomized controlled trial. Gerontologist. 1994;34:307-315.
35. Nazareth I, Burton A, Shulman S, et al. A pharmacy discharge plan for hospitalized elderly patients - a randomized controlled trial. Age Ageing. 2001;30:33-40.
36. Al-Rashed SA, Wright DJ, Roebuck N, et al. The value of inpatient pharmaceutical counselling to elderly patients prior to discharge. Br J Clin Pharmacol. 2002; 54:657-664.
37. Hanlon JT, Weinberger M, Samsa GP, et al. A randomized controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med. 1996;100:428-437.
38. Cowper P, Weinberger M, Hanlon JT, et al. The cost-effectiveness of a clinical pharmacist intervention among elderly outpatients. Pharmacotherapy. 1998;18:327-332.
39. Zermansky AG, Petty DR, Raynor DK, et al. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ. 2001;323:1340-1343.
40. Gattis WA, Hasselblad V, Whellan DJ, O'Connor CM. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: Results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) study. Arch Intern Med. 1999;159:1939-1945.
41. Bernsten C, Bjorkman I, Caramona M, et al. Improving the well-being of elderly patients via community pharmacy-based provision of pharmaceutical care: A multicentre study in seven European countries. Drugs Aging. 2001; 18:63-77.
42. Avorn J, Soumerai SB, Everitt DE, et al. A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes. N Engl J Med. 1992;327:168-173.
43. Roberts MS, Stokes JA, King MA, et al. Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. Br J Clin Pharmacol 2001;51:257-265.
44. Stadnyk K, Calder J, Rockwood K. Testing the measurement properties of the Short Form-36 Health Survey in a frail elderly population. J Clin Epidemiol. 1998;51:827-835.